Evidence map›Paper›PMID 39810784›Full record

ArticleKidney international reports2025

Response to Avoid Preclinical Errors When Using Urine Biomarkers of Exposure.

Arthur D Stem, Stephen Brindley, Keegan L Rogers, Adil Salih, Carlos A Roncal-Jimenez, Richard J Johnson, Lee S Newman, Jaime Butler-Dawson, Lyndsay Krisher, Jared M Brown

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arthur D StemDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Stephen BrindleyDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Keegan L RogersDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Adil SalihDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Carlos A Roncal-JimenezDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Richard J JohnsonDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Lee S NewmanDepartment of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado, Aurora, Colorado, USA.
Jaime Butler-DawsonDepartment of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado, Aurora, Colorado, USA.
Lyndsay KrisherDepartment of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado, Aurora, Colorado, USA.
Jared M BrownDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Funding

Silica Nephropathy and Chronic Kidney Disease of Unknown EtiologyR01DK125351 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Jared Michael Brown, LEE S NEWMAN · 2020 to 2026
$4.0M
NIDDK NIH HHS R01 DK125351
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39810784
PMCPMC11725806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.